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Abstract 
The rarest subtype of malignant fibrous histiocytoma (MFH) is the inflammatory type, 
which due to its peculiar clinical presentation may mimic an infectious process such as 
an abscess. The rarity of this disease and the unique features of its presentation may 
mislead the surgeon with consequent catastrophic results for the patient. In this study, a 
case report of a 65-year-old female patient with a soft-tissue inflammatory MFH 
presenting as a lumbar abscess and a review of the current literature are presented. 
 
Introduction 
Malignant fibrous histiocytoma (MFH) is the most common soft-tissue sarcoma of 
adults aged >45 years, involving most commonly the extremities and the 
retroperitoneum, with a slight male-gender predomination. The inflammatory type of 
MFH is the rarest of all and is characterized by a predominance of xanthoma cells with an 
intense neutrophilic infiltration. There is no consensus regarding the best diagnostic and 
treatment modality of inflammatory MFH, although most authors agree that surgery 
plays a pivotal role. We present a patient who was admitted to our hospital with a 
misdiagnosis of an abscess formation, although the patient suffered from a soft-tissue 
paraspinal MFH of the inflammatory type. Case Rep Oncol 2011;4:343–349 
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Case Presentation 
A 65-year-old female patient was admitted to our surgical department, complaining of a painful 
lumbar mass with high fever, which developed a few days after falling down the stairs. Physical 
examination revealed a temperature of 39°C and a palpable, protruding, fluctuating, and erythematous 
lumbar mass. Past medical history was unremarkable. Routine laboratory data on admission showed 
leukocytosis (WBC 41,270/μl, PMNs 87%) and anemia (Hct 29.6%, Hb 9.2 g/dl). ECG recordings and 
chest radiographs were normal. 
Contrast-enhanced ultrasound (CEUS) revealed a hypoechoic mass of 9.8 × 8 × 11 cm with an 
irregular and heterogeneous structure and abundant vascularization. Having not excluded in our 
differential diagnosis an abscess formation, paracentesis was performed which revealed pus with 
abundant pyospheres and a negative culture. A wide drainage procedure was decided on, and sticky 
material was encountered along with extensive bleeding from the tumor site. Biopsy material was sent 
for pathological examination. Postoperatively, there was no clinical and biochemical improvement and 
our patient remained distressed, despite the use of wide spectrum intravenous antibiotics. 
Abdominal CT scan was performed, and the report led to the diagnosis of a paraspinal abscess 
formation (fig. 1). Under ultrasound guidance, percutaneous drainage was attempted unsuccessfully 
due to the thick consistency of the tumor content. A repeat ultrasound examination showed 
pronounced vascularization inside an ill-defined structure with contrast material oozing from the 
paracentesis site, thus a sarcoma was suspected by the radiologists. 
At that time, we obtained the biopsy results that showed malignant fibrous histiocytoma of 
inflammatory type. Immunohistochemistry revealed positive reactivity to CD68 and vimentin and 
negative reactivity to CKAE1, CKAE3, EMA, CD45, CD15, CD30, S100, HMB45, MELAN-A, actin, 
desmin, MVOD1, CD34, CD99, chromogranin, and synaptophysin (fig. 2). Our patient was scheduled 
for magnetic resonance imaging, which showed a large heterogeneous space-occupying lesion with 
lobular peripheral architecture at the anatomical site of the right sacrospinalis muscle, with signs of 
malignant infiltration of the right iliac bone (fig. 3). 
After an oncological consultation meeting, the tumor was considered inoperable and the patient was 
scheduled for neoadjuvant radiotherapy. Unfortunately, excessive bleeding occurred that required 
multiple transfusions. Finally, our patient died 5 months after the initial presentation of the disease. 
Written informed consent was obtained from the patient for publication of this case report and any 
accompanying images. A copy of the written consent is available for review by the Editor-in-Chief of 
this journal. 
Discussion 
MFH is the commonest type of soft-tissue sarcomas, representing 28% of all sarcomas. 
It was first described in 1964 as ‘malignant fibrous xanthomas’ after an extensive analysis 
of 53 cases which possessed histiocytic and fibroblastic elements with a storiform pattern, 
accompanied by inflammatory, xanthomatous, and pleomorphic giant cells [1]. MFHs 
occur more frequently in the extremities, followed by the abdominal cavity and the 
retroperitoneum [2], even though these tumors may be found in any part of the body, 
including the digestive tract, spermatic cord, kidney, pancreas, spleen, lung, thymus, 
ovaries, and gallbladder [2]. Inflammatory MFH is a rare subtype which was first 
described as ‘inflammatory fibrous histiocytoma’ [3], due to the intense acute 
inflammatory infiltrate in the absence of known infectious agents and unassociated with 
tissue necrosis. At present, inflammatory MFH is classified as a unique variant of MFH 
which commonly affects the retroperitoneum and, less frequently, the extremities [4]. 
Patients with retroperitoneal tumors develop constitutional symptoms including 
malaise, weight loss, anorexia, and abdominal discomfort. Apart from these symptoms, Case Rep Oncol 2011;4:343–349 
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patients suffering from inflammatory MFH tumors present with fever, leukocytosis with 
neutrophilic or eosinophilic predomination and elevated serum C-reactive protein [5]. 
Thus, it is not unusual to consider an abscess formation in the differential diagnosis, as in 
our case. Some studies have documented that inflammatory MFHs have eosinophilic and 
neutrophilic chemotactic activity, which could potentially explain the blood chemistry 
profile and the abundant neutrophil infiltration of the tumor [6]. There are an increasing 
number of reports that implicate an association of accidental or surgical trauma and the 
pathogenesis of MFH [7]. This hypothesis applies to our case, since our patient had 
reported a recent fall at the site of the tumor. We believe that trauma plays an important 
role in the development of MFH, but further studies are needed for clarification. 
Imaging modalities are helpful in providing data about the size, location, vasculature, 
extension of the tumor, and in designing preoperatively the extent of the surgical excision. 
Inflammatory MFH quite often present as well-defined lesions, with hypoechoic features, 
with or without intralesional calcifications at abdominal real-time ultrasound scanning 
[8]. Computer tomography scanning with intravenous contrast agents shows muscle 
density patterns, and, as occurred in our case, these tumors are mostly hypervascular with 
an early wash-out venous phase [9], even though less frequently, these tumors might be 
hypovascular due to tissue necrosis and hemorrhage [10]. Magnetic resonance imaging 
has not proved helpful in distinguishing between benign and malignant lesions. De 
Schepper et al. [11] found that the signs that had the greatest specificity and sensitivity for 
malignancy included ‘absence of low signal intensity on T2’, ‘signal inhomogeneity on 
T1’, and ‘mean diameter of the lesion greater than 33 mm’. Kalayanarooj [12] concluded 
that features that favor malignancy with statistical significance were heterogeneous signal 
on T2-weighted, perilesional edema or invasion, and necrosis in the masses. Definitive 
diagnosis can be made only by biopsy, which should be taken at multiple sites to avoid 
misdiagnosis [4]. 
Surgical wide excision with tumor-free margins remains the principal modality with 
intent to cure. Given the fact that MFH has a poor prognosis with high local recurrence 
rates and distant metastasis especially with tumors larger than 10 cm [13], special 
attention has been given to the role of adjuvant therapies. Adjuvant therapy, until 
recently, has failed to improve survival, keeping the 5-year survival rate between 12 and 
70% [14]. Chemotherapy is not effective and radiotherapy is limited by toxicity to the 
adjacent organs, thus aggressive successful en bloc resection of the primary tumor and 
local recurrences remains the most important prognostic factor [15]. 
Conclusion 
Inflammatory MFH represents a unique subtype of MFH, which is extremely rare and 
quite often mimics an abscess formation due to the blood chemistry profile and its clinical 
presentation. It has a poor prognosis with high recurrence and low survival rates. 
Inflammatory MFH should be included in the differential diagnosis in patients with a 
large retroperitoneal mass and systemic inflammatory response syndrome, especially with 
a personal history of trauma at the tumor site. The best therapeutic approach is an 
aggressive wide surgical resection of the tumor mass en bloc.  Case Rep Oncol 2011;4:343–349 
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Fig. 1. An axial computed tomography demonstrating a right paraspinal abscess. 
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Fig. 2. a Phagocytic activity of neoplastic cells (H&E, × 200); b positive reactivity of malignant 
xanthomatous cells (CD68, × 400); c positive reactivity of malignant cells (vimentin, × 200). 
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Fig. 3. Magnetic resonance imaging (sagittal and coronary views) demonstrating a large heterogeneous 
mass with lobular peripheral architecture at the anatomical site of the right sacrospinalis muscle, with 
malignant infiltration of the right iliac bone. 
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